Bi-104

N/A

Report date: 2024/05/09 16:23:15

Base Information

Drug NameBi-104
Drug Alias NameDiversifyBi104Bi-104
ClassificationNatural product/Extract > Microbial extract
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsAngelman Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBIOM Pharmaceutical Corporation
China Registration ClassN/A

Develop Information

Active CompaniesBIOM Pharmaceutical Corporation
Inactive CompaniesN/A
Active IndicationsAngelman Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A